评估 18F-FDG PET/CT 在不同治疗节点的 DLBCL 患者中的治疗效果和预后价值。

IF 3.1 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Wenyu Zhao, Xiaodong Wu, Shuo Huang, Hui Wang, Hongliang Fu
{"title":"评估 18F-FDG PET/CT 在不同治疗节点的 DLBCL 患者中的治疗效果和预后价值。","authors":"Wenyu Zhao, Xiaodong Wu, Shuo Huang, Hui Wang, Hongliang Fu","doi":"10.1186/s13550-024-01074-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the present study, we aimed to investigate the role of baseline (B), interim (I) and end-of-treatment (Eot) <sup>18</sup>F-FDG PET/CT in assessing the prognosis of diffuse large B cell lymphoma (DLBCL), so as to identify patients who need intensive treatment at an early stage.</p><p><strong>Methods: </strong>A total of 127 DLBCL patients (62 men; 65 women; median age 62 years) were retrospectively analyzed in this study. Baseline (n = 127), interim (n = 127, after 3-4 cycles) and end-of-treatment (n = 53, after 6-8 cycles) PET/CT images were re-evaluated; semi-quantitative parameters such as maximum standardized uptake value of lesion-to-liver ratio (SUVmax<sub>(LLR)</sub>) and lesion-to-mediastinum ratio (SUVmax<sub>(LMR)</sub>), total metabolic tumor volume (TMTV) and total metabolic tumor volume (TLG) were recorded. ΔTLG<sup>1</sup> was the change of interim relative to baseline TLG (I to B), ΔTLG<sup>2</sup> (Eot to B). ΔSUVmax and ΔTMTV were the same algorithm. The visual Deauville 5-point scale (D-5PS) has been adopted as the major criterion for PET evaluation. Visual analysis (VA) and semi-quantitative parameters were assessed for the ability to predict progression-free survival (PFS) and overall survival (OS) by using Kaplan-Meier method, cox regression and logistic regression analysis. When visual and semi-quantitative analysis are combined, the result is only positive if both are positive.</p><p><strong>Results: </strong>At a median follow-up of 34 months, the median PFS and OS were 20 and 32 months. The survival curve analysis showed that advanced stage and IPI score with poor prognosis, ΔSUVmax<sub>(LLR)</sub><sup>1</sup> < 89.2%, ΔTMTV<sup>1</sup> < 91.8% and ΔTLG<sup>1</sup> < 98.8%, ΔSUVmax<sub>(LLR)</sub><sup>2</sup> < 86.4% were significantly related to the shortening of PFS in patient (p < 0.05). ΔSUVmax<sub>(LLR)</sub><sup>1</sup> < 83.2% and ΔTLG<sup>1</sup> < 97.6% were significantly correlated with the shortening of OS in patients (p < 0.05). Visual analysis showed that incomplete metabolic remission at I-PET and Eot-PET increased the risk of progress and death. In terms of predicting recurrence by I-PET, the combination of visual and semi-quantitative parameters showed higher positive predictive value (PPV) and specificity than a single index.</p><p><strong>Conclusion: </strong>Three to four cycles of R-CHOP treatment may be a time point for early prediction of early recurrence/refractory (R/R) patients and active preemptive treatment. Combined visual analysis with semi-quantitative parameters of <sup>18</sup>F-FDG PET/CT at interim can improve prognostic accuracy and may allow for more precise screening of patients requiring early intensive therapy.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10876506/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluation of therapeutic effect and prognostic value of <sup>18</sup>F-FDG PET/CT in different treatment nodes of DLBCL patients.\",\"authors\":\"Wenyu Zhao, Xiaodong Wu, Shuo Huang, Hui Wang, Hongliang Fu\",\"doi\":\"10.1186/s13550-024-01074-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In the present study, we aimed to investigate the role of baseline (B), interim (I) and end-of-treatment (Eot) <sup>18</sup>F-FDG PET/CT in assessing the prognosis of diffuse large B cell lymphoma (DLBCL), so as to identify patients who need intensive treatment at an early stage.</p><p><strong>Methods: </strong>A total of 127 DLBCL patients (62 men; 65 women; median age 62 years) were retrospectively analyzed in this study. Baseline (n = 127), interim (n = 127, after 3-4 cycles) and end-of-treatment (n = 53, after 6-8 cycles) PET/CT images were re-evaluated; semi-quantitative parameters such as maximum standardized uptake value of lesion-to-liver ratio (SUVmax<sub>(LLR)</sub>) and lesion-to-mediastinum ratio (SUVmax<sub>(LMR)</sub>), total metabolic tumor volume (TMTV) and total metabolic tumor volume (TLG) were recorded. ΔTLG<sup>1</sup> was the change of interim relative to baseline TLG (I to B), ΔTLG<sup>2</sup> (Eot to B). ΔSUVmax and ΔTMTV were the same algorithm. The visual Deauville 5-point scale (D-5PS) has been adopted as the major criterion for PET evaluation. Visual analysis (VA) and semi-quantitative parameters were assessed for the ability to predict progression-free survival (PFS) and overall survival (OS) by using Kaplan-Meier method, cox regression and logistic regression analysis. When visual and semi-quantitative analysis are combined, the result is only positive if both are positive.</p><p><strong>Results: </strong>At a median follow-up of 34 months, the median PFS and OS were 20 and 32 months. The survival curve analysis showed that advanced stage and IPI score with poor prognosis, ΔSUVmax<sub>(LLR)</sub><sup>1</sup> < 89.2%, ΔTMTV<sup>1</sup> < 91.8% and ΔTLG<sup>1</sup> < 98.8%, ΔSUVmax<sub>(LLR)</sub><sup>2</sup> < 86.4% were significantly related to the shortening of PFS in patient (p < 0.05). ΔSUVmax<sub>(LLR)</sub><sup>1</sup> < 83.2% and ΔTLG<sup>1</sup> < 97.6% were significantly correlated with the shortening of OS in patients (p < 0.05). Visual analysis showed that incomplete metabolic remission at I-PET and Eot-PET increased the risk of progress and death. In terms of predicting recurrence by I-PET, the combination of visual and semi-quantitative parameters showed higher positive predictive value (PPV) and specificity than a single index.</p><p><strong>Conclusion: </strong>Three to four cycles of R-CHOP treatment may be a time point for early prediction of early recurrence/refractory (R/R) patients and active preemptive treatment. Combined visual analysis with semi-quantitative parameters of <sup>18</sup>F-FDG PET/CT at interim can improve prognostic accuracy and may allow for more precise screening of patients requiring early intensive therapy.</p>\",\"PeriodicalId\":11611,\"journal\":{\"name\":\"EJNMMI Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10876506/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13550-024-01074-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-024-01074-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

研究背景本研究旨在探讨基线(B)、中期(I)和治疗末期(Eot)18F-FDG PET/CT在评估弥漫大B细胞淋巴瘤(DLBCL)预后中的作用,从而识别早期需要强化治疗的患者:本研究对127例DLBCL患者(62例男性;65例女性;中位年龄62岁)进行了回顾性分析。重新评估了基线(n = 127)、中期(n = 127,3-4 个周期后)和治疗末期(n = 53,6-8 个周期后)PET/CT 图像;记录了病灶与肝脏比值(SUVmax(LLR))和病灶与纵隔比值(SUVmax(LMR))的最大标准化摄取值、总代谢肿瘤体积(TMTV)和总代谢肿瘤体积(TLG)等半定量参数。ΔTLG1 是相对于基线 TLG 的中期变化(I 到 B),ΔTLG2 是相对于基线 TLG 的中期变化(Eot 到 B)。ΔSUVmax和ΔTMTV的算法相同。PET 评估的主要标准是多维尔 5 点目测量表(D-5PS)。采用 Kaplan-Meier 法、cox 回归法和 logistic 回归分析法评估了视觉分析(VA)和半定量参数预测无进展生存期(PFS)和总生存期(OS)的能力。将直观分析和半定量分析结合起来,只有两者均为阳性时,结果才为阳性:中位随访 34 个月,中位 PFS 和 OS 分别为 20 个月和 32 个月。生存曲线分析显示,晚期和 IPI 评分与预后不良有关,ΔSUVmax(LLR)1 1 1 (LLR)2 (LLR)1 1 结论:三至四个周期的 R-CHOP 治疗可能是早期预测早期复发/难治(R/R)患者和积极进行先期治疗的一个时间点。在中期结合 18F-FDG PET/CT 的半定量参数进行视觉分析可提高预后的准确性,并可更精确地筛选出需要早期强化治疗的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients.

Background: In the present study, we aimed to investigate the role of baseline (B), interim (I) and end-of-treatment (Eot) 18F-FDG PET/CT in assessing the prognosis of diffuse large B cell lymphoma (DLBCL), so as to identify patients who need intensive treatment at an early stage.

Methods: A total of 127 DLBCL patients (62 men; 65 women; median age 62 years) were retrospectively analyzed in this study. Baseline (n = 127), interim (n = 127, after 3-4 cycles) and end-of-treatment (n = 53, after 6-8 cycles) PET/CT images were re-evaluated; semi-quantitative parameters such as maximum standardized uptake value of lesion-to-liver ratio (SUVmax(LLR)) and lesion-to-mediastinum ratio (SUVmax(LMR)), total metabolic tumor volume (TMTV) and total metabolic tumor volume (TLG) were recorded. ΔTLG1 was the change of interim relative to baseline TLG (I to B), ΔTLG2 (Eot to B). ΔSUVmax and ΔTMTV were the same algorithm. The visual Deauville 5-point scale (D-5PS) has been adopted as the major criterion for PET evaluation. Visual analysis (VA) and semi-quantitative parameters were assessed for the ability to predict progression-free survival (PFS) and overall survival (OS) by using Kaplan-Meier method, cox regression and logistic regression analysis. When visual and semi-quantitative analysis are combined, the result is only positive if both are positive.

Results: At a median follow-up of 34 months, the median PFS and OS were 20 and 32 months. The survival curve analysis showed that advanced stage and IPI score with poor prognosis, ΔSUVmax(LLR)1 < 89.2%, ΔTMTV1 < 91.8% and ΔTLG1 < 98.8%, ΔSUVmax(LLR)2 < 86.4% were significantly related to the shortening of PFS in patient (p < 0.05). ΔSUVmax(LLR)1 < 83.2% and ΔTLG1 < 97.6% were significantly correlated with the shortening of OS in patients (p < 0.05). Visual analysis showed that incomplete metabolic remission at I-PET and Eot-PET increased the risk of progress and death. In terms of predicting recurrence by I-PET, the combination of visual and semi-quantitative parameters showed higher positive predictive value (PPV) and specificity than a single index.

Conclusion: Three to four cycles of R-CHOP treatment may be a time point for early prediction of early recurrence/refractory (R/R) patients and active preemptive treatment. Combined visual analysis with semi-quantitative parameters of 18F-FDG PET/CT at interim can improve prognostic accuracy and may allow for more precise screening of patients requiring early intensive therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
EJNMMI Research
EJNMMI Research RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍: EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies. The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信